Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balances at beginning (in shares) at Dec. 31, 2022   24,578,983    
Balances at beginning at Dec. 31, 2022 $ 36,887 $ 246 $ 187,008 $ (150,367)
Issuances of common stock:        
Share-based compensation (in shares)   9,538    
Share-based compensation 6,079   6,079  
Option exercises (cashless) (in shares)   14,312    
Issuance of common stock under employee stock purchase plan (in shares)   84,430    
Issuance of common stock under employee stock purchase plan 506 $ 1 505  
Payments for taxes related to net share settlement of equity awards (in shares)   (34,534)    
Payments for taxes related to net share settlement of equity awards (210)   (210)  
Net loss for the year $ (22,089)     (22,089)
Balance at ending (in shares) at Dec. 31, 2023 24,652,729 24,652,729    
Balances at ending at Dec. 31, 2023 $ 21,173 $ 247 193,382 (172,456)
Issuances of common stock:        
Public offering of common stock, net of offering costs (in shares)   2,653,848    
Public offering of common stock, net of offering costs 16,183 $ 26 16,157  
Share-based compensation (in shares)   260,552    
Share-based compensation 6,907 $ 2 6,905  
Option exercises (cash and cashless) (in shares)   12,258    
Option exercises (cash and cashless) 21   21  
Issuance of common stock under employee stock purchase plan (in shares)   97,093    
Issuance of common stock under employee stock purchase plan 443 $ 1 442  
Payments for taxes related to net share settlement of equity awards (in shares)   (59,065)    
Payments for taxes related to net share settlement of equity awards (424)   (424)  
Net loss for the year $ (18,914)     (18,914)
Balance at ending (in shares) at Dec. 31, 2024 27,617,415 27,617,415    
Balances at ending at Dec. 31, 2024 $ 25,389 $ 276 $ 216,483 $ (191,370)